Jyothy Labs Confirms End of Pril and Fa Licences, Outlines Next Phase of Growth

5 min read     Updated on 10 May 2026, 02:11 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Jyothy Labs Limited disclosed under Regulation 30 of SEBI LODR that Henkel AG & Co. KGaA will not renew the Pril and Fa brand licence agreements beyond May 31, 2026, ending a 15-year association. The Board reviewed the matter on May 9, 2026, and the Company has initiated transition measures including scaling up Exo dishwash liquid, with near-term revenue and margin impacts acknowledged while medium and long-term business fundamentals are described as intact.

powered bylight_fuzz_icon
39864332

*this image is generated using AI for illustrative purposes only.

Jyothy Labs Limited has issued a press release and clarification note following Henkel AG & Co. KGaA's decision not to renew the licence agreements for the Pril and Fa brands beyond May 31, 2026. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, following a Board of Directors meeting held on May 9, 2026. The development marks the close of a 15-year association during which Jyothy Labs built and scaled the Pril and Fa brands in India. The Company is now preparing for an orderly transition and the next phase of growth led by owned brands.

Background of the Licence Arrangements

In 2011, Jyothy Labs acquired Henkel's India consumer business through a composite transaction covering brands, assets, operations, and distribution capabilities. As part of this arrangement, the brand portfolio was structured across three categories of ownership and licensing. The key details of the licence agreements are summarised below:

Parameter: Details
Parties to the Agreement: Erstwhile Henkel India Limited (since amalgamated with Jyothy Labs Limited) and Henkel AG & Co. KGaA
Nature of Agreement: Licence Agreements and Technology Licence Agreements for manufacturing, distribution, marketing and sale under Pril and Fa brands
Date of Execution: May 31, 2011
Status: Agreements will not be renewed beyond May 31, 2026
Financial Impact: Currently under evaluation

The broader brand portfolio under the 2011 transaction was structured as follows:

Brand(s): Arrangement
Pril and Fa: Fixed-term brand licence agreements with Henkel; royalties and defined exit provisions apply
Mr. White and Henko: Perpetual Licence arrangements with no royalty obligations
Margo, Neem Toothpaste, Tuhina, Chek: Fully owned by Jyothy Labs

Regulatory Disclosure

In compliance with applicable SEBI regulations, Jyothy Labs filed the following disclosure with the stock exchanges on May 9, 2026. The Annexure A, enclosed with the filing, contains the structured disclosure as required under Regulation 30:

Sr. No: Particulars: Details
A. Name of parties to the Agreement Erstwhile Henkel India Limited (since amalgamated with Jyothy Labs Limited) and Henkel AG & Co. KGaA
B. Nature of the Agreement Licence Agreements and Technology Licence Agreements for manufacturing, distribution, marketing and sale under Pril and Fa brands
C. Date of execution of the Agreement May 31, 2011
D. Details of amendment/termination and impact The Agreements may stand non-renewed beyond May 31, 2026. The financial impact is currently under evaluation.

The disclosure was signed and filed by Shreyas Trivedi, Head – Legal & Company Secretary of Jyothy Labs Limited, on May 9, 2026.

Board Review and Non-Renewal Conclusion

Over the past several months, Jyothy Labs and Henkel were engaged in ongoing discussions and negotiations regarding the possible continuation and renewal of the brand licence arrangements beyond May 31, 2026. Various commercial and business continuity alternatives were also explored between the parties during this period. On May 9, 2026, the Board of Directors reviewed the status of these discussions, together with the communication received from Henkel. Based on the overall status of the discussions and the absence of a mutually acceptable framework for continuation, the Board concluded that there was no further reasonable certainty regarding renewal of the Pril and Fa brand licence agreements beyond May 31, 2026. The Company will now follow the exit and transition mechanism prescribed under the relevant agreements, including the process relating to Business Transfer and determination of consideration as contemplated under the contractual framework. The Company will continue to engage with Henkel constructively and in accordance with the agreed contractual process.

Transition Strategy and Portfolio Readiness

Jyothy Labs has already initiated transition planning measures and outlined its strategy for the next phase of growth led by owned brands. The company's approach to business continuity is centred on the following:

  • Within the dishwash segment, Pril has historically been the anchor brand in liquids, while Exo has anchored the bars segment. The current development provides an opportunity to strengthen Exo as a holistic dishwash franchise spanning formats. Exo dishwash liquid has been part of the Company's portfolio since 2005-06 and is now being scaled up with renewed focus and investment.
  • The Fa brand's contribution to the Company's overall business has been limited, and its exit does not materially alter the Company's operating fundamentals.
  • Manufacturing facilities are multi-product and flexible, allowing capacity redeployment across liquids and other growth categories. The Company does not expect any material stranded manufacturing exposure arising solely from this transition.
  • The Company's broader portfolio across fabric care, home care, and personal care, supported by strong distribution and a steady innovation pipeline, remains unchanged.

The Company also clarified that the brand licence agreements contain a contractual mechanism for determination of consideration linked to the business momentum and goodwill created during the licence period, and this process will be pursued in accordance with the contractual framework. The transition framework under the agreements is structured and defined, including a goodwill mechanism, and Jyothy Labs will take all appropriate steps within the contractual framework to protect the interests of the Company and its stakeholders.

Financial Implications

The Company recognises that Pril has been an important contributor within the dishwash liquids segment. Accordingly, there could be certain near-term impacts on revenue mix and margins during the transition phase. The Company has already initiated transition measures including scale-up and strengthening of Exo dishwash liquid, dishwash category actions, manufacturing realignment, and other business continuity initiatives. The Company presently believes that the medium and long-term fundamentals of its business remain intact, supported by its diversified portfolio, established distribution network, manufacturing capabilities, and execution strength. Jyothy Labs remains committed to transparent communication, disciplined execution, and long-term value creation, and further updates will be made as and when required in accordance with applicable law and regulatory requirements.

Management Commentary

M R Jyothy, CMD of Jyothy Labs Limited, commented on the development:

"Pril and Fa were an important part of our journey for nearly 15 years. Henkel's decision brings that chapter to a close. We are confident in our ability to manage this transition responsibly and build the next phase of growth. Our focus remains on continuity, scaling our brands, and long-term value creation for our stakeholders."

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+1.12%-1.60%+22.52%-16.31%-29.96%+77.76%

How quickly can Exo dishwash liquid realistically capture the market share currently held by Pril, and what marketing investments will Jyothy Labs need to deploy to accelerate this transition?

What is the likely quantum of goodwill consideration Jyothy Labs could receive from Henkel under the contractual Business Transfer mechanism, and how might this be deployed to fund brand-building for owned labels?

Could Henkel re-enter the Indian dishwash and personal care market independently or through another partner following the licence expiry, potentially creating a new competitive threat for Jyothy Labs?

Jyothy Labs Schedules One-on-One Investor Meeting with Nalanda Capital on May 11, 2026

1 min read     Updated on 09 May 2026, 04:36 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Jyothy Labs Limited has intimated stock exchanges of a one-on-one physical investor meeting with Nalanda Capital scheduled for May 11, 2026, filed on May 8, 2026, under SEBI Regulation 30. The company confirmed no Unpublished Price Sensitive Information will be shared, and the meeting schedule is subject to change due to exigencies. The filing was signed by Shreyas Trivedi, Head – Legal & Company Secretary.

powered bylight_fuzz_icon
39815787

*this image is generated using AI for illustrative purposes only.

Jyothy Laboratories Limited has notified the stock exchanges of a scheduled one-on-one physical investor meeting with Nalanda Capital, set to take place on May 11, 2026. The intimation was filed on May 8, 2026, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The following table outlines the key details of the scheduled investor interaction as disclosed by the company:

Parameter: Details
Date of Meeting: May 11, 2026
Name of Fund / Investor: Nalanda Capital
Type of Meeting: One-on-One
Meeting Format: Physical

Regulatory Compliance and Disclosure

The company has explicitly stated that no Unpublished Price Sensitive Information (UPSI) is proposed to be shared during the aforesaid investor meeting. The intimation was submitted to both BSE Limited and the National Stock Exchange of India Limited as part of the company's ongoing disclosure obligations under applicable SEBI regulations.

Jyothy Labs Limited has also noted that the schedule of the meeting may undergo change due to exigencies on the part of the investor or the company. The latest Investor Presentation is available on the company's official website at www.jyothylabs.com .

The filing was signed by Shreyas Trivedi, Head – Legal & Company Secretary, on behalf of Jyothy Labs Limited, and is dated May 8, 2026.

Historical Stock Returns for Jyothy Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+1.12%-1.60%+22.52%-16.31%-29.96%+77.76%

Could Nalanda Capital's one-on-one meeting with Jyothy Labs signal a potential increase or decrease in its stake, and how might such a move impact the stock's institutional ownership profile?

How has Jyothy Labs' recent financial performance and product portfolio expansion influenced institutional investor interest heading into 2026?

What strategic priorities — such as new product launches, margin improvement, or geographic expansion — is Jyothy Labs likely to highlight to attract long-term institutional investors like Nalanda Capital?

More News on Jyothy Laboratories

1 Year Returns:-29.96%